Trial site
Oviedo
Oviedo, Principality of Asturias 33011, SpainNot linked to an institution yet
The trials here
What the 6 trials at this site are about, from their registry records.
- Phase
- Phase 34 trials
- Phase 21 trial
- Phase 41 trial
- Status
- Completed4 trials
- Terminated2 trials
- Lead sponsor
- Novartis Pharmaceuticals6 trials
Closed trials
Recruiting
Long-term Safety and Tolerability of Inclisiran in Participants With HeFH or HoFH Who Have Completed the Pediatric ORION-16, ORION-13, ORION-20, or ORION-19 Studies
NCT05682378· Phase 3· Novartis Pharmaceuticals· Source
Contact: Novartis Pharmaceuticals
Completed
Study of Efficacy, Safety, Tolerability and Quality of Life of Inclisiran (KJX839) vs Placebo, on Top of Ongoing Individually Optimized Lipid-lowering Therapy, in Participants With Hypercholesterolemia
NCT05192941· Phase 4· Novartis Pharmaceuticals· Source
Terminated
Study of Efficacy and Safety of MBG453 in Combination With Azacitidine in Subjects With Intermediate, High or Very High Risk Myelodysplastic Syndrome (MDS) as Per IPSS-R, or Chronic Myelomonocytic Leukemia-2 (CMML-2)
NCT04266301· Phase 3· Novartis Pharmaceuticals· Source
Terminated
A Study of the Anti-PD1 Antibody PDR001, in Combination With Dabrafenib and Trametinib in Advanced Melanoma
NCT02967692· Phase 3· Novartis Pharmaceuticals· Source
Completed
LDK378 Versus Chemotherapy in Previously Untreated Patients With ALK Rearranged Non-small Cell Lung Cancer
NCT01828099· Phase 3· Novartis Pharmaceuticals· Source
Completed
Nilotinib Treatment-free Remission Study in CML (Chronic Myeloid Leukemia) Patients
NCT01784068· Phase 2· Novartis Pharmaceuticals· Source
Report an error